Global Coronavirus Disease 2019 Test Kit Market Outlook 2022

Laboratory testing for the respiratory coronavirus disease 2019 (COVID-19) and the associated SARS-CoV-2 virus includes methods that detect the presence of virus and those that detect antibodies produced in response to infection. Detection of antibodies (serology) can be used both for clinical purposes and population surveillance.Using real time reverse transcription polymerase chain reaction (rRT-PCR) the test can be done on respiratory samples obtained by various methods, including nasopharyngeal swab or sputum sample.Results are generally available within a few hours to 2 days.Molecular methods leverage polymerase chain reaction (PCR) along with nucleic acid tests, and other advanced analytical techniques, to detect the genetic material of the virus using real-time reverse transcription polymerase chain reaction for diagnostic purposes.

The global Coronavirus Disease 2019 Test Kit market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Coronavirus Disease 2019 Test Kit volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Coronavirus Disease 2019 Test Kit market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Coronavirus Disease 2019 Test Kit Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.


Segment by Type
Nucleic Acid Test Kit
Antibody Test Kit


Segment by Application
Hospital
Scientific Research
Diagnostic Center


By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE


By Company
Thermo Fisher Scientific
LabCorp
Cepheid
Hologic
Danaher
Roche Diagnostics
BioMérieux
Integrated DNA Technologies
Abbott Laboratories
Beijing Genomics Institute
Shanghai Huirui Biotechnology
Geneodx
Shanghai BioGerm Medical Biotechnology
Da An Gene
Wondfo
INNOVITA
Kogenebiotech
Mylab Discovery
Altona Diagnostics
Seegene
SD Biosensor
Biomaxima
Quidel
Qiagen
GenMark Diagnostics